Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.C.P.S (Medicine), F.C.P.S (Gastroenterology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.C.P.S (Medicine), F.C.P.S (Gastroenterology)
Gastroenterologist
MBBS, MACG (USA), MD (Gastroenterology)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S.
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MRCP-ll(UK)
General Physician
MBBS, MRCP Diabetes and Endocrinology (RCP London), MRCP Internal Medicine (RCP London), CCT (UK)
General Physician
MBBS, MRCP Diabetes and Endocrinology (RCP London), MRCP Internal Medicine (RCP London), CCT (UK)
Gastroenterologist
MBBS, MCPS (Internal Medicine), FCPS (Gastroenterology & Hepatology), M.A.C.G (USA)
Gastroenterologist
MBBS, MCPS (Internal Medicine), FCPS (Gastroenterology & Hepatology), M.A.C.G (USA)
Dermatologist
M.B.B.S, M.R.C.P (UK)
Gastroenterologist
M.B.B.S., M.D (Gastro), MACG(America)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures